Cytokeum任命Sung Lee为CFO

2024-04-27 04:32

Cytokinetics (NASDAQ:CYTK) appointed Sung Lee to the role of Executive Vice President, Chief Financial Officer, effective as of May 8.
On the start date, Lee will assume the duties and responsibilities of the company’s principal financial officer from Robert Blum, the company’s president and CEO, who has been serving as principal financial officer on an interim basis, according to a filing.
Lee, 53, has served as the CFO of Vir Biotechnology since March 2023 and will be stepping down from the role effective May 3, in order to join the company.
Previously, from February 2021 to March 2023, he served as CFO and Management Board member of MorphoSys AG, a biopharmaceutical company.

More on Cytokinetics